These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 32973534)
41. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616 [TBL] [Abstract][Full Text] [Related]
42. A mini-review on the impact of COVID 19 on vital organs. Shah MD; Sumeh AS; Sheraz M; Kavitha MS; Venmathi Maran BA; Rodrigues KF Biomed Pharmacother; 2021 Nov; 143():112158. PubMed ID: 34507116 [TBL] [Abstract][Full Text] [Related]
43. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2. Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758 [TBL] [Abstract][Full Text] [Related]
44. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets. Karmouty-Quintana H; Thandavarayan RA; Keller SP; Sahay S; Pandit LM; Akkanti B Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138181 [TBL] [Abstract][Full Text] [Related]
45. Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury. Wang LL; Yang JW; Xu JF Clin Microbiol Infect; 2022 Apr; 28(4):513-520. PubMed ID: 34861410 [TBL] [Abstract][Full Text] [Related]
46. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. Groß S; Jahn C; Cushman S; Bär C; Thum T J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703 [TBL] [Abstract][Full Text] [Related]
47. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis. Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743 [TBL] [Abstract][Full Text] [Related]
48. The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials. Lumbers ER; Delforce SJ; Pringle KG; Smith GR Front Med (Lausanne); 2020; 7():248. PubMed ID: 32574336 [TBL] [Abstract][Full Text] [Related]
49. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783 [TBL] [Abstract][Full Text] [Related]
50. Cardiovascular impact of COVID-19: an array of presentations. Maab H; Mustafa F; Shabbir SJ Acta Biomed; 2021 May; 92(2):e2021021. PubMed ID: 33988162 [TBL] [Abstract][Full Text] [Related]
51. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2. Zheng J; Miao J; Guo R; Guo J; Fan Z; Kong X; Gao R; Yang L Front Cell Infect Microbiol; 2022; 12():931061. PubMed ID: 35774402 [TBL] [Abstract][Full Text] [Related]
52. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19. Chatterjee SK; Saha S; Munoz MNM Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977 [TBL] [Abstract][Full Text] [Related]
53. Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients. Azinheira Nobrega Cruz N; Gonçalves de Oliveira LC; Tedesco Silva Junior H; Osmar Medina Pestana J; Casarini DE Front Physiol; 2021; 12():700220. PubMed ID: 34497535 [TBL] [Abstract][Full Text] [Related]
54. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection. Rochette L; Ghibu S Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751 [TBL] [Abstract][Full Text] [Related]
55. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV. Li SR; Tang ZJ; Li ZH; Liu X Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1021-1026. PubMed ID: 32285293 [TBL] [Abstract][Full Text] [Related]
56. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Bian J; Li Z Acta Pharm Sin B; 2021 Jan; 11(1):1-12. PubMed ID: 33072500 [TBL] [Abstract][Full Text] [Related]
57. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure. Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504 [TBL] [Abstract][Full Text] [Related]
58. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people? Xu K; Wei Y; Giunta S; Zhou M; Xia S Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906 [TBL] [Abstract][Full Text] [Related]
59. The Immune Response and Immunopathology of COVID-19. Mortaz E; Tabarsi P; Varahram M; Folkerts G; Adcock IM Front Immunol; 2020; 11():2037. PubMed ID: 32983152 [TBL] [Abstract][Full Text] [Related]
60. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]